Activation of factor VIII and mechanisms of cofactor action

被引:168
作者
Fay, PJ
机构
[1] Univ Rochester, Sch Med, Dept Biochem, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med, Dept Biophys, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
关键词
factor VIII; factor VIIIa; factor IXa; intrinsic factor Xase; factor X; catalytic rate constant; thrombin; factor Xa;
D O I
10.1016/S0268-960X(03)00025-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The factor VIII procofactor circulates as a metal ion-dependent heterodimer of a heavy chain and light chain. Activation of factor VIII results from limited proteolysis catalyzed by thrombin or factor Xa, which binds the factor VIII substrate over extended interactive surfaces. The proteases efficiently cleave factor VIII at three sites, two within the heavy and one within the light chain resulting in alteration of its covalent structure and conformation and yielding the active cofactor, factor VIIIa. The role of factor Villa is to markedly increase the catalytic efficiency of factor IXa in the activation of factor X. This effect is manifested in a dramatic increase in the catalytic rate constant, k(cat), by mechanisms that remain poorly understood. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 115 条
[41]  
LAMPHEAR BJ, 1992, BLOOD, V80, P3120
[42]  
Lapan KA, 1997, J BIOL CHEM, V272, P2082
[43]   Interaction of the A1 subunit of factor VIIIa and the serine protease domain of Factor X identified by zero-length cross-linking [J].
Lapan, KA ;
Fay, PJ .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (03) :418-422
[44]   Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding [J].
Lenting, PJ ;
Christophe, OD ;
terMaat, H ;
Rees, DJG ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (41) :25332-25337
[45]   CLEAVAGE AT ARGININE-145 IN HUMAN BLOOD-COAGULATION FACTOR-IX CONVERTS THE ZYMOGEN INTO A FACTOR-VIII BINDING ENZYME [J].
LENTING, PJ ;
TERMAAT, H ;
CLIJSTERS, PPFM ;
DONATH, MJSH ;
VANMOURIK, JA ;
MERTENS, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) :14884-14890
[46]   The sequence Glu(1811)-Lys(1818) of human blood coagulation factor VIII comprises a binding site for activated factor IX [J].
Lenting, PJ ;
vandeLoo, JWHP ;
Donath, MJSH ;
vanMourik, JA ;
Mertens, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :1935-1940
[47]   The life cycle of coagulation factor VIII in view of its structure and function [J].
Lenting, PJ ;
van Mourik, JA ;
Mertens, K .
BLOOD, 1998, 92 (11) :3983-3996
[48]  
LENTING PJ, 1994, J BIOL CHEM, V269, P7150
[49]   THE INTERACTION BETWEEN HUMAN BLOOD-COAGULATION FACTOR-VIII AND VONWILLEBRAND-FACTOR - CHARACTERIZATION OF A HIGH-AFFINITY BINDING-SITE ON FACTOR-VIII [J].
LEYTE, A ;
VERBEET, MP ;
BRODNIEWICZPROBA, T ;
VANMOURIK, JA ;
MERTENS, K .
BIOCHEMICAL JOURNAL, 1989, 257 (03) :679-683
[50]  
Liles DK, 1997, BLOOD, V90, P2054